Press Releases

Date Title and Summary Additional Formats
Toggle Summary Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2015
RANCHO CUCAMONGA, Calif. , May 29, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell , President will be presenting at the Jefferies Healthcare Conference on Wednesday, June 3, 2015 at 10:00 a.m. Eastern Time in New York, NY .
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Net Revenues of $56.9 Million for the First Quarter Ended March 31, 2015
RANCHO CUCAMONGA, Calif. , May 13, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the first quarter ended March 31, 2015 . Net revenues of $56.9 million for the first quarter GAAP net loss of $0.7 million , or $0.01
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
RANCHO CUCAMONGA, Calif. , May 11, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell , President will be presenting at the Bank of America Merrill Lynch 2015 Health Care Conference on Thursday, May 14, 2015 at 9:20 a.m.
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 13, 2015
RANCHO CUCAMONGA, Calif. , May 7, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its first quarter of 2015 ended March 31, 2015 , after the market closes on Wednesday, May 13, 2015 , and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
RANCHO CUCAMONGA, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell, President will be presenting at the 14 th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 12:10 p.m.
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $55.9 Million for the Fourth Quarter Ended December 31, 2014
RANCHO CUCAMONGA, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the fourth quarter ended December 31, 2014. Net revenues of $55.9 million for the fourth quarter GAAP net loss of $2.5 million, or
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 24, 2015
RANCHO CUCAMONGA, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its fourth quarter of 2014 ended December 31, 2014, after the market closes on Tuesday, March 24, 2015, and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014
RANCHO CUCAMONGA, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the third quarter ended September 30, 2014. Net revenues of $59.7 million for the third quarter GAAP net loss of $5.4 million or $0.12
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 12, 2014
RANCHO CUCAMONGA, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its third quarter of 2014 ended September 30, 2014, after the market closes on Wednesday, November 12, 2014, and will hold a conference call
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $49.0 Million for the Second Quarter Ended June 30, 2014
RANCHO CUCAMONGA, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2014. Net revenues of $49.0 million for the second quarter GAAP net loss of $1.2 million or $0.03 per
View HTML

 

Copyright ©2018 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States